article thumbnail

How AI-Powered ECG Analysis is Advancing Cardiometabolic Research: Our Latest Study with University Hospital Basel

Cardiomatics

We are proud to share our latest study, conducted with University Hospital Basel, and published in Diabetes Care. A key focus of the research was heart rate variability (HRV)analyzed using our AI-powered ECG technology. This is our fourth research project with University Hospital Basel, and we are excited about whats next.

article thumbnail

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

DAIC

Genesis is the latest advancement in Robotic Magnetic Navigation technology. PPMC, part of the University of Pennsylvania Health System, renowned for advanced clinical research, innovation, and compassionate patient care, stands at the forefront as the first in the Northeast United States to offer the Genesis System.

article thumbnail

RCE Technologies, Inc. Announces First-In-Human Transdermal Continuous Cardiac Biomarker Monitoring

DAIC

RCE Technologies, Inc. RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. Featured in an ACC.24 Featured in an ACC.24

article thumbnail

What’s New in MRI Technology — 2024 Edition

Cassling

With so many technological advancements happening across all of healthcare, it’s easy to lose sight of the incredible evolution happening to one of the cornerstones of the hospital imaging experience: MRI.

article thumbnail

Narrative review: updates and strategies for reducing door-to-balloon time in ST-elevation myocardial infarction care

Frontiers in Cardiovascular Medicine

This narrative review aims to evaluate strategies for reducing door-to-balloon (D2B) time in ST-elevation myocardial infarction (STEMI) patients, focusing on pre-hospital, in-hospital, and technological innovations, as well as addressing challenges to ensure sustainability.

article thumbnail

Bodyport Presents Preliminary Analysis of SCALE-HF 1 Study on Remote Heart Failure Monitoring at Technology and Heart Failure Therapeutics (THT) Conference

DAIC

a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care. Bodyport Inc., Image courtesy: Bodyport Inc. produced by the standard of care.

article thumbnail

New Technology Promises to Revolutionize Valvular Heart Disease Care

DAIC

Getty Images milla1cf Mon, 04/01/2024 - 08:21 April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number. “We